Form 3PYXSCIK 0001782223

Pyxis Oncology, Inc.

Name: SEC EDGAR filing 0000950170-24-071435
Creator: Pyxis Oncology, Inc.
License: https://www.usa.gov/government-works

Initial insider ownership (Form 3) filed June 10, 2024.

Initial statement of beneficial ownership filed by a company's officers, directors, and 10%+ owners when they first become an insider.

Read the filing on SEC.gov All documents in this filing

Filing facts

Accession number: 0000950170-24-071435
Filer: Pyxis Oncology, Inc.
Ticker: PYXS
CIK: 0001782223
Form type: Form 3
Form description: Initial insider ownership
Filed at: June 10, 2024
Period of report: June 10, 2024
Industry: SIC 2834Pharmaceutical Preparations
Filing size: 24.7 KB
Last verified: August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from Pyxis Oncology, Inc.

See all 45 filings from Pyxis Oncology, Inc. →

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1782223/000095017024071435/0000950170-24-071435-index.htm ↗

Filer's full EDGAR submission history

EDGAR · Pyxis Oncology, Inc. (0001782223) ↗

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.